Abstract
Background:
Dysphagia as a main manifestation of extrapyramidal symptoms is an uncommon adverse effect of second-generation antipsychotics.
Method:
We present a 54-year-old drug-naïve patient with schizophrenia, who developed dysphagia with aripiprazole 30 mg daily treatment.
Results:
This is the first case report on aripiprazole-induced dysphagia. We discuss the risk factors that led to dysphagia in this case.
Conclusion:
Aripiprazole-induced dysphagia is rare, and it is important to beaware that it does occur with high-dosage treatment. © 2011 by Wiley Periodicals, Inc. (Int J Eat Disord 2011;)